Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Lindgren

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
Lakartidningen|March 3, 2007
[Acute liver failure--rapid multidisciplinary management]Einar Björnsson, Gu Wei, Annika Bergquist, et al.
Journal of Hepatology|December 17, 2008
Hepatic and extrahepatic malignancies in autoimmune hepatitis. A long-term follow-up in 473 Swedish patientsMårten Werner, Sven Almer, Hanne Prytz, et al.
Gastroenterology|July 23, 2009
Increased mortality risk in patients with phenotypic hereditary hemochromatosis but not in their first-degree relativesMaria Elmberg, Rolf Hultcrantz, Fereshte Ebrahim, et al.
Journal of Crohn'S & Colitis|December 28, 2016
Five-year Safety Data From ENCORE, a European Observational Safety Registry for Adults With Crohn's Disease Treated With Infliximab [Remicade®] or Conventional TherapyGeert D'Haens, Walter Reinisch, Jean-Frederic Colombel, et al.
Journal of Hepatology|February 28, 2002
Hepatic and extrahepatic malignancies in primary sclerosing cholangitisAnnika Bergquist, Anders Ekbom, Rolf Olsson, et al.
Gastroenterology|January 16, 2004
Cancer risk in patients with hereditary hemochromatosis and in their first-degree relativesMaria Elmberg, Rolf Hultcrantz, Anders Ekbom, et al.
Scandinavian Journal of Gastroenterology|January 20, 2010
Characteristics and long-term outcome of patients with autoimmune hepatitis related to the initial treatment responseMårten Werner, Sven Wallerstedt, Stefan Lindgren, et al.
Journal of Crohn'S & Colitis|February 28, 2019
Five-year Safety Data From OPUS, a European Observational Safety Registry for Adults With Ulcerative Colitis Treated With Originator Infliximab [Remicade®] or Conventional TherapyJulián Panés, James O Lindsay, Niels Teich, et al.
Annals of Medicine|January 11, 2021
Questions and answers on iron deficiency treatment selection and the use of intravenous iron in routine clinical practiceToby Richards, Christian Breymann, Matthew J Brookes, et al.
Scandinavian Journal of Gastroenterology|December 9, 2014
Hepatocellular and extrahepatic cancer in patients with autoimmune hepatitis--a long-term follow-up study in 634 Swedish patientsÅsa Danielsson Borssén, Sven Almer, Hanne Prytz, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Lakartidningen|March 3, 2007
[Acute liver failure--rapid multidisciplinary management]Einar Björnsson, Gu Wei, Annika Bergquist, et al.
Journal of Hepatology|December 17, 2008
Hepatic and extrahepatic malignancies in autoimmune hepatitis. A long-term follow-up in 473 Swedish patientsMårten Werner, Sven Almer, Hanne Prytz, et al.
Gastroenterology|July 23, 2009
Increased mortality risk in patients with phenotypic hereditary hemochromatosis but not in their first-degree relativesMaria Elmberg, Rolf Hultcrantz, Fereshte Ebrahim, et al.
Journal of Crohn'S & Colitis|December 28, 2016
Five-year Safety Data From ENCORE, a European Observational Safety Registry for Adults With Crohn's Disease Treated With Infliximab [Remicade®] or Conventional TherapyGeert D'Haens, Walter Reinisch, Jean-Frederic Colombel, et al.
Journal of Hepatology|February 28, 2002
Hepatic and extrahepatic malignancies in primary sclerosing cholangitisAnnika Bergquist, Anders Ekbom, Rolf Olsson, et al.
Gastroenterology|January 16, 2004
Cancer risk in patients with hereditary hemochromatosis and in their first-degree relativesMaria Elmberg, Rolf Hultcrantz, Anders Ekbom, et al.
Scandinavian Journal of Gastroenterology|January 20, 2010
Characteristics and long-term outcome of patients with autoimmune hepatitis related to the initial treatment responseMårten Werner, Sven Wallerstedt, Stefan Lindgren, et al.
Journal of Crohn'S & Colitis|February 28, 2019
Five-year Safety Data From OPUS, a European Observational Safety Registry for Adults With Ulcerative Colitis Treated With Originator Infliximab [Remicade®] or Conventional TherapyJulián Panés, James O Lindsay, Niels Teich, et al.
Annals of Medicine|January 11, 2021
Questions and answers on iron deficiency treatment selection and the use of intravenous iron in routine clinical practiceToby Richards, Christian Breymann, Matthew J Brookes, et al.
Scandinavian Journal of Gastroenterology|December 9, 2014
Hepatocellular and extrahepatic cancer in patients with autoimmune hepatitis--a long-term follow-up study in 634 Swedish patientsÅsa Danielsson Borssén, Sven Almer, Hanne Prytz, et al.
Pageof 11